(Q44717786)

English

Reduction and residual proteinuria are therapeutic targets in type 2 diabetes with overt nephropathy: a post hoc analysis (ORIENT-proteinuria).

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Reduction and residual proteinuria are therapeutic targets in type 2 diabetes with overt nephropathy: a post hoc analysis (ORIENT-proteinuria). (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

type 2 diabetes

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Juliana Chung-ngor Chan

3

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

object named as

Sadayoshi Ito

6

0 references

author name string

Enyu Imai

1

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Masakazu Haneda

2

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Tetsu Yamasaki

4

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Fumiaki Kobayashi

5

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Hirofumi Makino

7

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

language of work or name

0 references

publication date

7 September 2013

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Nephrology Dialysis Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

28

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

2526-2534

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT249

21 January 2018

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT249

21 January 2018

Effects of olmesartan on renal and cardiovascular outcomes in type 2 diabetes with overt nephropathy: a multicentre, randomised, placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT249

21 January 2018

Proteinuria should be used as a surrogate in CKD.

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT249

21 January 2018

Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAAL.

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT249

21 January 2018

Proteinuria reduction and progression to renal failure in patients with type 2 diabetes mellitus and overt nephropathy

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT249

21 January 2018

Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT249

21 January 2018

Importance of baseline distribution of proteinuria in renal outcomes trials: lessons from the reduction of endpoints in NIDDM with the angiotensin II antagonist losartan (RENAAL) study

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT249

21 January 2018

Changes in albuminuria predict mortality and morbidity in patients with vascular disease

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT249

21 January 2018

Prognosis and risk factors for idiopathic membranous nephropathy with nephrotic syndrome in Japan

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT249

21 January 2018

Proteinuria as a surrogate outcome in CKD: report of a scientific workshop sponsored by the National Kidney Foundation and the US Food and Drug Administration

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT249

21 January 2018

initial angiotensin receptor blockade-induced decrease in albuminuria is associated with long-term renal outcome in type 2 diabetic patients with microalbuminuria: a post hoc analysis of the IRMA-2 trial

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT249

21 January 2018

Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT249

21 January 2018

Identifiers

10.1093/NDT/GFT249

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44717786&oldid=1811053823"